Why this matters: JEF faces a conflicting analyst picture four days before earnings. UBS downgraded the stock this morning even as it raised its price target. Options markets have grown more cautious over the same period.
UBS made a split move on Wednesday. Analyst Michael Brown downgraded Jefferies from Buy to Neutral. He simultaneously raised his price target from $59 to $67.
That's a rare combination — lower conviction, higher target. It reflects how far the stock has run. JEF is up 18.5% over the past month, closing at $61.88 on Tuesday.
Oppenheimer sits at the other end. Chris Kotowski maintained his Outperform rating on June 12 and raised his target sharply — from $72 to $87. That's the most bullish call on the street right now. Morgan Stanley and BMO both raised targets too, but neither moved off neutral ratings.
The consensus sits at Hold. The mean price target is $63.50, just 2.6% above the current price.
The put-call ratio has climbed steadily since mid-June. It hit 0.7833 on June 17. That's 2.5 standard deviations above the 20-day mean of 0.74.
Put demand has built even as the stock rallied. That divergence is notable. It suggests some participants are paying up for downside protection heading into the June 22 earnings print.
The 52-week PCR range runs from 0.29 to 1.87. At 0.78, the current reading is elevated but not extreme relative to history.
Short interest rose 37% over the past month to 2.60% of free float. That is still a low absolute level. It does not constitute a crowded short.
The daily swings have been large — up 71% in one week, down 11% in a single day on June 17. That volatility in SI reflects repositioning, likely tied to the earnings date and the stock's rapid move higher.
The borrowing market remains wide open. Availability sits at 3,148% — meaning roughly 31 shares are available to borrow for every one currently borrowed. Cost to borrow fell 50% over the past week to 0.247%. There is no lending-market pressure on shorts.
The most significant institutional move in recent months was Sumitomo Mitsui Financial Group's purchase of 15.7 million shares on May 1 — a $310 million position. That stake now represents 7.7% of the company. CEO Richard Handler sold 1.44 million shares in late May at $52.43, pocketing $75.5 million. The stock has since risen another 18% from that sale price.
See the live data behind this article on ORTEX.
Open JEF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
